Capital Medical University

Capital Medical University (CMU) ranks among the top academic medical institutions in China, with 10 Schools, 20 affiliated hospitals and 1 teaching institution. CMU and its affiliated hospitals have a staff of over 20,000; among them, over 1,000 professors, 2,000 associate professors and 10,000 enrolled students. CMU provides a wide range of educational programs for Doctorates, Masters, Bachelors and certificates. CMU has been well-funded by the MoST, China and also China National Sciences Foundation (NSFC). CMU has also been actively participating international collaborations, including the projects granted by WHO, NIH, Welcome Trust, EU-frame Projects, JSPS, NSF, NHMRC and Pasture Institute.

Prof W Wang

Prof W Wang is the ex-dean of School of Public Health and Family Medicine, CMU. Currently he is professor /director of the Centre of Excellence for Clinical Epidemiology, CMU. He holds the honorary positions as Fellow of the Public Health Faculty, Royal College of Physicians (UK), Fellow of Royal Society of Biology (UK); Visiting professor of University Edinburgh; Adjunct Professor of North Western University, Chicago, USA, and Adjunct Professor of University at Buffalo, The State University of New York, USA. Prof Wang’s contributions to medical sciences include service as an Australian National Representative of European Association of Predictive, Preventive and Personalized Medicine (EPMA), member of the expert panel advising WHO on its ‘Grand Challenges in Genomics for Public Health in Developing Countries’, steering committee member of OECD initiative on Public Health Genomics, and member of the Global Health Epidemiology Reference Group, (GHERG).

Prof WZ Wang

Prof WZ Wang is a neuro-epidemiologist. He is the Director of BNI’s Neuro-epidemiology Department, Director of the National Office for CVD Prevention and Control, MoH, China. His research focused on cerebrovascular disease, epilepsy and dementia and especially on exploring risk factors of neurological disorders, the effective measures in community level to prevent and control stroke, epilepsy, and dementia. He is the recipient of the awards from China State Council and MoH for research achievements on community control of epilepsy in rural China, population-based managements on hypertension and stroke. Of the most relevance to this purposed proposal is his successful completion of the WHO collaborative project “Demonstration Project of Epilepsy Control in Rural China” (2000 – 2004), supported by the MoST & MoH, between 2004 and 2012, the project has been extended as a model covering 201 counties in 18 provinces of China.

Prof Q Zeng

Prof Q Zeng is a Professor/Director at the Health Management Institute, PLA General Hospital, China. He is the president of Chinese Association of Health Management (CAHM). His contributions to medical science include services as Vice President of the Life Technologies Institute (Asia), affiliated to UNESCO, Fellow of the International Society for Heart Research. His expertise is on health prevention and management. He is one of the leading experts on mHealth in China and his CAHM will provides the national-wide network on eHealth/mHealth promotion.

Dr MS Song

Dr MS Song is an Associate Professor in Epidemiology at CMU. She is also a chief scientist of the Municipal Key Laboratory of Clinical Epidemiology, Beijing Municipal Government, China. She was awarded PhD by the Chinese Academy of Sciences in 2005. Her principal research interests are genetic epidemiology, population genetics and bioinformatics. She is skilled in epidemiological field work, SNP genotyping, and software packages (Epidata, SeqScape, HotspotFisher, PHASE, Hotspotter, LDdat, RepeatMasker, Haplopainter, Cyrillic, R Package).

Dr YX Wang

Dr YX Wang, an epidemiologist, is the Vice Director/ Associate Professor of the Key Laboratory of Clinical Epidemiology, Beijing Municipal Government, China. Based on his expertise on research design and fieldwork on NCD, he has over 30 research publications including articles, reports and letters in Science, Nat Rev Cancer, NEJM, Lancet, JAMA, J Proteome Res, Anticancer Res, and PLoS ONE. He currently leads the Chinese suboptimal health cohort study (COACS).